Oncology
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Attrition rate
Real-world study shows high attrition rate across all LOTs
- These high attrition rates underscore the need to use the most optimal treatment regimens upfront rather than reserving them for later LOTs in which the clinical benefit may decrease
Non-transplant patients
Transplant patients
LOT, line of therapy.
Fonseca R, et al. BMC Cancer. 2020;20(1):1087.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.